miles ford

mRNA therapeutics and Vaccines market Professional Survey Report by 2035

The “mRNA Therapeutics and Vaccines Market: Industry Trends and Global Forecasts, 2022 – 2035” report features an extensive study of the current market landscape and the likely future potential associated with the biopharmaceutical contract manufacturing market, over the next decade.

The study also includes an elaborate discussion on the future potential of this evolving market. Amongst other elements, the report features:

Key Inclusions
 A detailed overview of the overall market landscape of mRNA therapeutics and vaccines, based on several relevant parameters, such as phase of development (marketed, phase III, phase II, phase I / II, phase I, preclinical and discovery), type of drug candidate (mRNA therapeutic and mRNA vaccine), therapeutic area (infectious diseases, oncological disorders, genetic disorders, pulmonary disorders, autoimmune disorders and other disorders), type of delivery system used (lipid nanoparticles, lipopolyplex, liposomes, direct transfer, self-amplifying RNA platform and others), type of molecule encoded (spike protein, glycoprotein, antigen, cytokine, protein coding gene, tumor neoantigen, enzyme, tumor antigen and others) and route of administration (intramuscular, intravenous, intranasal and others).
 A detailed overview of the current mRNA therapeutics and mRNA vaccine market of players engaged in the development of mRNA therapeutics and vaccines, along with information on their year of establishment, company size (in terms of number of employees), location of headquarters, regional landscape and key players engaged in this domain.
 An in-depth company competitiveness analysis of mRNA therapeutics and vaccines developers based on their portfolio strength (in terms of year of establishment and company size), pipeline strength (in terms of its pipeline maturity and drug administration route) and number of therapeutic areas targeted.
 Detailed profiles of marketed and late stage (phase III) mRNA therapeutics and vaccines, along with information on the development timeline of the therapy, current development status, primary target indication, therapeutic area, type of molecule encoded, type of delivery system used, affiliated technology, recent partnerships associated with the drug, clinical trial results related to the drug and other recent developmental.
 A review of the various mRNA-focused initiatives undertaken by big pharma players (shortlisted on the basis of the revenues generated in 2021), featuring a [A] heat map representation that highlights mRNA therapeutics and vaccines under development (in partnership with core mRNA-focused entities), along with information on funding amount raised, partnership activity, and diversity of product portfolio (in terms of disease indication(s) being treated and focus therapeutic area(s)), as well as [B] a spider web representation, comparing the initiatives of big pharmaceutical players on the basis of multiple relevant parameters.
 An analysis of start-ups (established between 2016-2022) engaged in this domain, based on several relevant parameters, such as number of candidates in discovery, preclinical and clinical phases of development, amount raised, number of investors and number of deals inked.
 An analysis of completed, ongoing and planned clinical studies of mRNA therapeutics and vaccines, based on several relevant parameters, such as trial registration year, trial status, trial phase, target therapeutic area, study design, type of sponsor / collaborator, leading industry players (in terms of number of trials conducted), enrolled patient population and key geographical regions.
 An analysis of recent collaborations and partnerships within the mRNA therapeutics and vaccines industry, based on several relevant parameters, such as year of partnership, type of partnership, targeted therapeutic area, most active players (in terms of number of deals inked) and regional distribution of partnership activity that have been undertaken in this domain, during the period 2013-2022.
 A detailed analysis of various investments made by players engaged in this domain, during the period 2013-2022, based on several relevant parameters, such as year of funding, type of funding (seed financing, venture capital, IPOs, secondary offerings, debt, grants and other offerings), amount invested, therapeutic area, most active players (in terms of number of funding instances and amount invested) and key investors (in terms of number of funding instances).
 An in-depth analysis of the various patents that have been filed / granted related to mRNA therapeutics and vaccines domain, since 2016, based on several relevant parameters, such as type of patent (granted patents, patent applications and others), publication year, geographical region, CPC symbols, leading industry players (in terms of the number of patents filed / granted) and patent valuation.

The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:

 Routes of Administration
 Intradermal
 Intravenous
 Intranasal
 Others

 Therapeutic Area
 Infectious Diseases
 Oncological Disorders
 Other Disorders

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Latin America
 Middle East and North Africa

Key Questions Answered
 Which are the key players engaged in the development of mRNA therapeutics and vaccines?
 Which mRNA drug candidates are being evaluated across early and late stages of clinical development?
 Which are the key therapeutic areas targeted by mRNA therapeutics and vaccines?
 Which type of delivery systems are primarily being used for the delivery of mRNA therapeutics and vaccines?
 Which are the most active trial sites (in terms of number of clinical studies being conducted) related to mRNA therapeutics and vaccines?
 Which companies are actively filing patents in order to drive innovation in the field of mRNA therapeutics and vaccines?
 What type of partnership models are commonly adopted by stakeholders in the mRNA therapeutics and vaccine domain?
 Which are the companies that are investing heavily in this domain?
 How is the current and future market opportunity likely to be distributed across the various key market segments?

To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/mrna-therapeutics-and-vaccines-market.html

News article
Modular Facility Manufacturers Market

Learn from experts: do you know about these emerging industry trends?
Novel Cell Cytometers: Need of the Hour
Antiviral Drugs: The Unmet Requirement in the Pharmaceutical Space

Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

Lab Automation market Growth Analysis and Forecast by 2035

The “Lab Automation Market, 2023-2035” report features an extensive study of the current market landscape and future potential of the lab automation market, over the next 12 years.

Key Inclusions
 An executive summary of the insights captured during our research, offering a high-level view on the current state of lab automation market and its likely evolution in the mid-to-long term.
 A general overview of lab automation, along with details on its historical evolution, different stages and processes. In addition, the chapter presents information on the advantages of lab automation and the challenges associated with its use. Further, it concludes with a discussion on the future perspectives in this domain.
 A detailed assessment of the overall market landscape of around 350 lab automation system manufacturers, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, types of lab automation system(s) (automated liquid handling systems (automated integrated workstations, pipetting systems and reagent dispensers), automated microplate systems (automated microplate workstations, microplate washers, multi-mode microplate readers and single-mode microplate readers), automated assay systems, automated nucleic acid extraction systems, robotic systems, automated storage and retrieval systems (ASRS), automated sampling systems and other lab automation equipment), stage(s) of automation (pre-analytical stage, analytical stage, post-analytical stage and total lab automation), application area(s) (drug discovery, diagnostics, genomic solutions, proteomic solutions, microbiology and other applications) and end-user(s) (pharmaceutical and biotechnology companies, research and academic institutes, hospitals and diagnostic laboratories and other end-users).
 A detailed competitiveness analysis of lab automation system manufacturers based on several relevant parameters, such as company strength (in terms of number of years since it was established), product diversity (in terms of number of lab automation system being developed by the company) and product strength (in terms of stage(s) of automation, application area(s) and end-user(s)).
 Elaborate profiles of key players (shortlisted based on a proprietary criterion) engaged in the development of lab automation systems across North America, Europe and Asia-Pacific and Rest of the World. Each profile features a brief overview of the company, details related to its financial information (if available), product portfolio, recent developments and an informed future outlook.
 A detailed analysis of partnerships inked between stakeholders engaged in this domain since 2018, based on several relevant parameters, such as year of partnership, type of partnership, type of partner, type of automation instrument(s), most active players (in terms of number of partnerships) and regional distribution of partnership activity in this domain.
 An in-depth analysis of various patents that have been filed / granted related to lab automation since 2018, taking into consideration several relevant parameters, such as patent publication year, type of patent, patent jurisdiction, CPC symbols, type of applicant, emerging focus areas and leading players (in terms of number of patents filled / granted) and leading individual assignees. It also features a detailed patent benchmarking analysis and an insightful valuation analysis, highlighting the leading patents (in terms of number of citations).
 Informed estimates of the existing market size and the future opportunity for lab automation instruments, over the next 12 years. Based on multiple parameters, such as global instrumentation market in life science industry, biopharmaceutical industry and share of automation, we have provided informed estimates on the evolution of the market for the period 2023-2035.
 A case study on the lab automation software providers, providing detailed analysis on various parameters such as year of establishment, company size (in terms of number of employees), location of headquarters, type of software (laboratory information management system, laboratory information system, electronic lab notebook, scientific data management system and other software), mode(s) of deployment (cloud-based and on-premise), end-user(s) (pharmaceutical and biotechnology companies, research and academic institutes, and hospitals and diagnostic laboratories).

The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
 Stage of Automation
 Pre-Analytical
 Analytical
 Post-Analytical
 Total Lab Automation

 Type of Instrument
 Automated Liquid Handling Systems
 Automated Microplate Readers
 Automated Sampling Systems
 Analyzers
 Automated Storage and Retrieval Systems (ASRS)
 Other Instruments

 End-User
 Pharmaceutical and Biotechnology Companies
 Research and Diagnostic Laboratories
 Other End-Users

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Middle East and North Africa
 Latin America

Key Questions Answered
 What is lab automation?
 What is automated liquid handling system? What are examples of liquid handling systems?
 How many players are currently involved in the development of lab automation systems?
 Which are the top players in the lab automation market?
 What is the global market size of the lab automation market?
 What is the growth rate of lab automation market?
 Which region is likely to hold the largest share in the lab automation market?
 What is the market share of automated liquid handling systems?
 What are the factors driving the lab automation market?

To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/lab-automation-market.html

News article
CAR-T cell therapy market

Learn from experts: do you know about these emerging industry trends?
Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders
T-cell Immunotherapies: The Future of Modern Cancer Treatments

Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

Cannabis Testing market Growth Analysis by 2035

The “Cannabis Testing Market, 2023-2035” report features an extensive study of the current landscape and the likely future potential of cannabis testing, over the next decade

Key Inclusions
 A detailed assessment of the overall market landscape of cannabis testing labs based on several relevant parameters, such as year of establishment, company size (in terms of employee count), location of headquarters, type of offering(s) (cannabis testing services or cannabis testing services & products), type of company (private company or public company), number of facilities (less than 5 facilities, 5 to 10 facilities, and more than 10 facilities), type of accreditation(s) / certification(s) (ISO, PJLA, DEA, A2LA, USDA, FDA, ELAP, AOAC, CDPHE, UKAS, NCIA, NELAP, DCC, ORELAP, HIA, CLIA, ANAB ANSI, and Others), number of accreditation(s) / certification(s) (less than 5 accreditations, 5-10 accreditations, and undisclosed), type of testing solution(s) offered (potency testing, terpenes testing, microbial analysis, pesticides testing, residual solvents testing, heavy metals testing, mycotoxins testing, moisture analysis, DNA genotyping, vitamin E acetate testing, and flavonoids testing), type of sample(s) tested (edibles and infused products, cannabis buds / flowers, cannabis extracts / concentrates, and cannabis oils), type of cannabis and hemp tested (by legal status - medical cannabis, hemp, recreational / adult-use cannabis, and others), and end-user(s) (cannabis cultivators / growers, cannabis drug / product manufacturers, cannabis edible manufacturers, and other research institutes).
 An insightful competitiveness analysis of cannabis testing labs based on company strength (in terms of years of experience), portfolio strength (in terms of type of company, number of facilities, type of offerings, number of testing solutions offered, number of samples tested, type of cannabis and hemp tested, and number of end-users) and number of accreditations / certifications.
 Elaborate profiles of key cannabis testing labs (shortlisted based on a proprietary criterion); each profile includes a brief overview of the company, along with information on its financial information (if available), service portfolio, recent developments and an informed future outlook.
 A detailed assessment of the overall market landscape of cannabis testing product providers, based on several relevant parameters, such as their year of establishment, company size (in terms of employee count), location of headquarters, type of offering(s) (cannabis testing products or cannabis testing services & products), type of testing product(s) offered (analytical instruments, consumables, reagents and additional software solutions), type of analytical instrument(s) offered (chromatography instruments, spectroscopy instruments and others), and type of additional software solution(s) offered (Laboratory Information Management System (LIMS), Customer Relationship Management (CRM), Enterprise Resource Planning (ERP)).
 A detailed analysis of the partnerships that have been inked within the cannabis testing market, since 2018, based on several relevant parameters, such as year of partnership, type of partnership (mergers and acquisitions, research and development agreements, service alliances, technology integration agreements, distribution agreements, licensing agreements and other agreements), type of partner (industry and non-industry), geographical location of the companies involved, and most active players (in terms of number of partnerships).
 An in-depth analysis of recent events (webinars / conferences / expos / summits) that were organized across different regions of the globe for stakeholders in this market, based on several relevant parameters, such as year of event, event platform, type of event, year and type of event, distribution of events by geography, evolutionary trends in event agenda / key focus area, most popular event organizers, most active industry players, most active non-industry players, most active speakers (in terms of number of events), details of the designation of speakers, affiliated department of event speakers and a geographical mapping of upcoming events.
 An insightful market forecast analysis, highlighting the likely growth of the cannabis testing market till the year 2035. In order to provide details on the future opportunity. Further, our projections have been segmented based on relevant parameters, such as type of cannabis tested (medical cannabis and recreational / adult-use cannabis), type of sample tested (flowers, extracts, edibles and other types of samples), company size (small, mid-sized and large companies) and key geographical regions (North America, Europe, Asia- Pacific, Latin America, and Middle East and North Africa).

The financial opportunity within the adeno-associated viral vector market has been analyzed across the following segments:
 Type of Cannabis Tested
 Medical Cannabis
 Recreational / Adult-use Cannabis
 Type of Sample Tested
 Flowers
 Extracts
 Edibles
 Others
 Company Size
 Large
 Mid-sized
 Small
 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Latin America
 Middle East and North Africa

The research also includes detailed profiles of the key players (listed below) engaged in the adeno-associated viral vector market; each profile features a brief overview of the company, its financial information (if available), details related to its manufacturing facilities and proprietary vector manufacturing technology portfolio, and recent developments and an informed future outlook.
 AccuScience Laboratories
 Anresco Labs
 CDX Analytics
 Coastal Analytical
 Eurofins Scientific
 EVIO Labs
 FoodChain ID
 LGC
 Medicine Creek Analytics
 SGS
 Tentamus

Key Questions Answered
 What are the various medical applications of cannabis?
 Which countries have legalized cannabis for medical use?
 Which are the top players in the cannabis testing market?
 What are the various factors driving cannabis testing market?
 Which region has the highest market share in cannabis testing market?
 Which are the leading market segments of the cannabis testing market?
 What is the growth rate (CAGR) of the cannabis testing market?
 What are the upcoming trends in the cannabis testing market?

To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/cannabis-testing-market.html

News article:
AI-based digital pathology market

Learn from experts: do you know about these emerging industry trends?
TIL Therapies: A New Paradigm in Cancer Treatment
Applications of Blockchain in Various Sectors: An Introduction

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
Ben.johnson@rootsanalysis.com

Cell Free Expression market Share, Growth Analysis by 2035

The “Cell Free System Market, 2023-2035” report features an extensive study of the current market landscape of players offering cell free expression services and cell free expression kits

Key Inclusions
 An executive summary of insights captured during our research. It offers a high-level view on the current state of the cell free expression market and its likely evolution in the given forecast period.
 A general overview of cell free system, the different types of such systems and their composition. It provides a brief outline of the cell free expression process, highlighting several challenges and advantages associated with this technique. It also features applications of cell free expression in the healthcare industry, as well as other industries and a discussion on future prospects of cell free expression.
 A detailed assessment of the current market landscape of cell free expression service providers, based on several relevant parameters, such as year of establishment, company size (in terms of employee count), location of headquarters, type of cell free service(s) offered (biomolecule synthesis / expression, template construction, scaled-up production, process optimization and feasibility testing), type of associated service(s) offered (purification, quality control and others), type of host organism (E. coli, wheat germ, HeLa / human cell lysate, rabbit reticulosyte, Nicotiana tabacum, Spodoptera frugiperda, Chinese hamster ovary, rice cell system, Saccharomyces cerevisiae and silkworm), type of product(s) synthesized (membrane proteins, toxic proteins, proteins with disulfide bonds / antibodies, protein complexes, soluble proteins, enzymes, modified proteins, antigens, insoluble proteins, high molecular weight proteins, other proteins, unspecified proteins and oligonucleotides), scale of operation (lab scale / pre-clinical, clinical and commercial) and type of industry served (pharmaceutical and biotechnology, academics, diagnostics, chemicals and food).
 A detailed assessment of the current market landscape of cell free expression kits, based on several relevant parameters, such as type of cell free system (crude cell lysate-based systems and reconstituted systems), type of host organism (microbial cell free expression system, plant-based cell free expression system, mammalian cell free expression system and insect-based cell free expression system), type of expression method (coupled transcription and translation method and translation method), type of product(s) synthesized (toxic proteins, soluble proteins, membrane proteins, labeled proteins, functionally active proteins, proteins with disulfide bonds, proteins with unnatural amino acids, high molecular weight proteins, insoluble proteins, heat-sensitive proteins, enzymes, other proteins, unspecified proteins, oligonucleotides and whole cells), type of template(s) used (circular DNA, linear DNA, RNA and others), type of compatible promoter(s) (T7, SP6 and others), type of reaction format (batch format, bilayer format, CECF format, and batch and CECF format), yield of positive control (1-5 µg/mL, >5-100 µg/mL, >100-200 µg/mL, >200-500 µg/mL, >500-1,000 µg/mL, >1,000-2,000 µg/mL, >2,000-3,000 µg/mL and >3,000 µg/mL), reaction volume (1-5 µL, >5-100 µL, >100-200 µL, >200-500 µL, >500-1,000 µL, >1,000-2,000 µL, >2,000-3,000 µL, >3,000-10,000 µL and >10,000 µL), reaction temperature (20°C-25°C, >25°C-30°C, >30°C-35°C and >35°C-40°C), incubation time (1-2 hours, >2-10 hours, >10-20 hours and >20 hours), number of reactions per kit (1-5 reactions / kit, >5-20 reactions / kit, >20-50 reactions / kit, >50-80 reactions / kit and >80-100 reactions / kit), price per kit (USD 150-200, USD >200-500, USD >500-1,000, USD >1,000-2,000, USD >2,000-3,000, USD >3,000-4,000, USD >4,000-5,000 and USD >5,000). In addition, it provides details on cell free expression kits developers, along with analyses based on their year of establishment, company size (in terms of employee count), location of headquarters and leading players (in terms of number of kits provided).
 A comprehensive company competitiveness analysis of cell free expression service providers based on supplier power (in terms of number of years of experience) and service strength (in terms of type of host organism, service(s) offered, number of product(s) synthesized, industries served and scale of operation).
 A product competitiveness analysis of cell free expression kits based on various relevant parameters, namely developer power (in terms of number of years of experience) and product competitiveness (in terms of type of cell free system, type of expression method, type of host organism, number of product(s) synthesized, number of template(s) used, number of compatible promoter(s), yield of positive control (µg/ml), reaction volume (µl), incubation time (hours), type of reaction format, reaction temperature and number of reactions per kit).
 Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering cell free expression services. Each profile features a brief overview of the company, details on its cell free expression service portfolio, recent developments and an informed future outlook.
 Elaborate profiles of prominent players engaged in development of cell free expression kits (shortlisted based on a proprietary criterion), featuring a brief overview of the company, details on its product portfolio, recent developments and an informed future outlook.
 A detailed analysis of recent partnerships inked between stakeholders engaged in this industry, since 2018, covering product development agreements, research and development agreements, technology licensing agreements, acquisitions, product licensing agreements, service alliances, asset acquisitions, joint ventures, product development and commercialization agreements, technology utilization agreements and other relevant agreements.
 An analysis of the funding and investments made in the market, since 2018, including seed financing, venture capital financing, capital raised from IPOs, secondary offerings, grants / awards, private placements, other equity and debt financing, at various stages of development in companies that are engaged in this field, based on several parameters, such as number of funding instances, amount invested, type of funding, leading players and investors, and geographical analysis.
 An in-depth analysis of various patents that have been filed / granted related to cell free system since 2015, taking into consideration several relevant parameters, such as patent publication year, type of patent, patent jurisdiction, CPC symbols, type of applicant, emerging focus areas, leading players (in terms of number of patents filled / granted) and leading individual assignees. It also features a detailed patent benchmarking analysis and an insightful valuation analysis, highlighting leading patents (in terms of number of citations)..

The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
 Type of Cell Free System
 Crude Cell Lysate-based Systems
 Reconstituted Systems

 Type of Host Organism
 Microbial Cell Free Expression Systems
 Mammalian Cell Free Expression Systems
 Plant-based Cell Free Expression Systems
 Other Cell Free Expression Systems

 Type of Expression Method
 Coupled Transcription and Translation Method
 Translation Method

 End-User
 Pharmaceutical and Biotechnology Companies
 Academic and Research Institutes
 Other End-Users

 Key Geographical Regions
 North America
 Europe
 Asia Pacific
 Rest of the World

Key Questions Answered
 What is the likely growth rate (CAGR) of cell free expression market?
 How big is the cell free expression market?
 Who are the key players offering cell free expression services?
 Who are the key developers of cell free expression kits, globally?
 What are the common partnership trends observed related to cell free systems?
 Which region captures the largest share of the cell free expression market?
 Which segments account for the largest cell free expression market share?

For additional details, please visit https://www.rootsanalysis.com/reports/cell-free-expression-market.html

News article
Biopharmaceutical Filtration Market

Learn from experts: do you know about these emerging industry trends?
CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications
T-cell Immunotherapies: The Future of Modern Cancer Treatments

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

Medical Device coating market Growth Analysis by 2035

The “Medical Device Coatings and Surface Modification Technologies Market, 2023-2035” report features an extensive study on the current market landscape, offering an informed opinion on the likely adoption of the medical device coatings and surface modification technologies in the healthcare industry, in the mid to long term.

Key Inclusions
 A detailed assessment of the overall market landscape of medical device coating providers, based on several relevant parameters, such as year of establishment, company size (based on the number of employees), location of headquarters, type of company (coating provider and service provider), type of medical device(s) coated (auditory devices, catheters, medical implants, ophthalmic devices, stents, surgical equipment, and other types of medical devices), nature of coating material(s) (natural and synthetic), type of coating material(s) (heparin, hydroxyapatite, hydrogel polymers, silicone, nylon, parylene, and other types of coating materials), type of coating(s) (hydrophilic and hydrophobic), type of coating function(s) (broad substrate compatibility, enhanced lubricity, antimicrobial properties, thermal stability, and corrosion resistance), type of compatible substrate(s) (fluoropolymers, metals, polyurethanes, polyolefins, and other types of substrates), service(s) offered (analytical testing services, coating services, customizability services, research and development services, and other key services), and additional feature(s) offered (durability and thin film coatings).
 A detailed competitiveness analysis of various medical device coating providers, based on several relevant parameters, such as supplier power (in terms of number of years of experience of a company), and service portfolio strength (in terms of type of company, type of medical device(s) coated, nature of coating material, type of coating materials(s), type of coating, type of compatible substrate material(s), type of coating function(s), and service(s) offered).
 A detailed assessment of the overall market landscape of medical device surface modification technologies and coating solutions, based on several relevant parameters, such as type of medium(s) for modification (coating solution and technology), type of trademark right (registered trademark and trademark), type of surface modification process(s) employed (chemical vapor deposition, covalent bonding, plasma enhanced chemical vapor deposition, plasma treatment, physical vapor deposition, thermal curing, UV curing, and other types of processes), type of device(s) coated (invasive devices and non-invasive devices), type of medical device(s) coated (catheters, diagnostic devices, implants, stents, surgical instruments, and other types of medical devices), nature of coating material(s) (synthetic and natural / API), type of coating(s) applied (hydrophilic and hydrophobic), type of resistance(s) offered (corrosion resistance, microbial resistance, thermal stability / resistance, and thrombogenic resistance), type of compatible substrate(s) (fluoropolymers, metals, polyurethanes, polyamides, polyolefins, and other types of substrates), and type of compatible substrate(s) (metals, fluoropolymers, polyurethanes, polyamides, polyolefins, and other types of substrates), additional feature(s) offered (customizability, durability, enhanced lubricity and thin layering).
 A detailed product competitiveness analysis of the various surface modification technologies and coating solutions, based on several relevant parameters, such as the developer power (in terms of number of years of experience of a company), and product competitiveness (in terms of medium(s) for modification, type of trademark right, type of process(s) employed, type of compatible substrate(s), nature of coating material(s), type of coating(s) applied, type of device(s) coated, type of medical device(s) coated, type of resistance(s) offered, and additional feature(s) offered).
 Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering medical device coatings. Each profile features a brief overview of the company, along with recent developments and an informed future outlook.
 An insightful analysis of the recent partnerships that have been inked within the surface modification technologies and coating solutions industry, since 2018, based on several relevant parameters, such as year of partnership, type of partnership (mergers and acquisitions, product commercialization agreements, product development agreements, product distribution agreements, product licensing and supply agreements, product manufacturing agreements, service alliances, and others), type of partner (industry and non-industry), geographical location of the companies involved, and most active players (in terms of number of partnerships).
 An insightful analysis of the leading medical device coating providers, considering the affiliated factors, key drivers, and challenges under the PESTLE framework, highlighting the relative effect of each factor of PESTLE parameter on the medical device coating providers.

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
 Type of Devices Coated
 Class I Medical Devices
 Class II Medical Devices
 Class III Medical Devices
 Type of Coating Material
 Polymer Coatings
 Metal Coatings
 Other Coatings
 Company Size
 Very Small
 Small
 Mid-sized
 Large
 Very Large
 Key Geographical Region
 North America
 Europe
 Asia
 Rest of the World

Key Questions Answered
 How is the medical device coating market anticipated to grow?
 Which type of partnership models are commonly adopted by stakeholders in the medical device coatings and surface modification technologies domain?
 What are the different types of coatings offered by big industry players involved in the medical device coatings market?
 What are the different substrates onto which, these coatings can be applied?
 Which region is likely to have the highest growth rate in medical device coatings market?
 Which segment, in terms of type of medical device coated, accounts for the largest share in the medical device coatings market?

To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/medical-device-coatings-market.html

You may also be interested in the following titles:
Digital Biomanufacturing Market
Smart pharmaceutical and healthcare labels: Lets trace medicines from its origin
Long-Acting Drug Delivery Technologies Market
Roots Analysis Consulting - the preferred research partner for global firms

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com